Chicken is the first sequenced avian that has a crucial role in human life for its meat and egg production. Because of various metabolic disorders, study the metabolism of chicken cell is important. Herein, the first genome-scale metabolic model of a chicken cell named iES1300, consists of 2427 reactions, 2569 metabolites, and 1300 genes, was reconstructed manually based on KEGG, BiGG, CHEBI, UNIPROT, REACTOME, and MetaNetX databases. Interactions of metabolic genes for growth were examined for E. coli, S. cerevisiae, human, and chicken metabolic models. The results indicated robustness to genetic manipulation for iES1300 similar to the results for human. iES1300 was integrated with transcriptomics data using algorithms and Principal Component Analysis was applied to compare context-specific models of the normal, tumor, lean and fat cell lines. It was found that the normal model has notable metabolic flexibility in the utilization of various metabolic pathways, especially in metabolic pathways of the carbohydrate metabolism, compared to the others. It was also concluded that the fat and tumor models have similar growth metabolisms and the lean chicken model has a more active lipid and carbohydrate metabolism.
Chicken is the first sequenced avian that has a crucial role in human life for its meat and egg production. Because of various metabolic disorders, study the metabolism of chicken cell is important. Herein, the first genome-scale metabolic model of a chicken cell named iES1300, consists of 2427 reactions, 2569 metabolites, and 1300 genes, was reconstructed manually based on KEGG, BiGG, CHEBI, UNIPROT, REACTOME, and MetaNetX databases. Interactions of metabolic genes for growth were examined for E. coli, S. cerevisiae, human, and chicken metabolic models. The results indicated robustness to genetic manipulation for iES1300 similar to the results for human. iES1300 was integrated with transcriptomics data using algorithms and Principal Component Analysis was applied to compare context-specific models of the normal, tumor, lean and fat cell lines. It was found that the normal model has notable metabolic flexibility in the utilization of various metabolic pathways, especially in metabolic pathways of the carbohydrate metabolism, compared to the others. It was also concluded that the fat and tumor models have similar growth metabolisms and the lean chicken model has a more active lipid and carbohydrate metabolism.
Metabolism is an important cellular process in a living cell. Thus, a deep understanding of metabolic networks is required [1]. Collected biological data about metabolic pathways has led us to reconstruct a genome-scale metabolic network that can be mathematically represented [2]. Constraint-based metabolic models are known to be structured models that consider a cell a multi-component system and contain detailed intracellular process information; while because of the black box nature of the models for some cases of machine learning (ML) approaches, further processing may be required to interpret the biological meaning of the model [3]. It should be noted that behaviour or understanding the models derived by ML algorithms is sometimes tough to comprehend or interpret, especially deep neural networks. These ML algorithms are considered examples of black-box models [4]. Therefore, metabolic models will be able to predict the conditions imposed on the cell more reliably [5]. This approach will bring the model prediction as close to reality as possible by considering constraints on the upper bounds of the metabolic reaction fluxes [6]. Besides, metabolic models gain higher predictive power by integration with omics data, which in this respect, their prediction will be more valid than other data-driven models [7]. In recent years, genome-scale metabolic models (GEMs) have been increasingly developed due to the advances in genome sequencing and annotation techniques [8, 9]. GEMs build a bridge between genotypic data and phenotypic traits [10].The importance of GEMs was strengthened when it was reported that manually and automated metabolic models have been submitted for more than 6200 organisms worldwide. More than 200 of these models belong to eukaryotes [11]. Following the reconstruction of the saccharomyces cerevisiae GEM in 2003 as the first eukaryotic model [12], the reconstruction of eukaryotic models became prevalent so that in 2007, the first human GEM RECON1 was reconstructed [2], and human GEMs continued to be updated with the expansion of the network [13], improvement of lipid metabolism [14], energy metabolism [15], and structural information [16]. Other studies in this area include mouse model reconstruction, which is known as the first attempt to reconstruct a mammalian model based on genomic data [17]. The mouse model was also updated in subsequent years using a human model [18]. Chinese Hamster Ovary (CHO) cells are the other interesting eukaryotic models that have been recently reconstructed because of their extensive applications in the biopharmaceutical industries [19, 20].While metabolic networks has been reconstructed for most of the important mammalians in the human life, no attempt has been yet made to reconstruct a metabolic network for chickens as an important source of food. Chickens are important eukaryotes because of their large population in animal husbandries and rural life as well as the annually high consumption of their egg and meat [21]. Studies on chicken first began in 1628 with an investigation on the functions of its arteries and veins. Then, chicken genetic research improved when the chicken’s first genetic map was constructed in 1936 [22]. Finally, in 2004, the genome sequencing of chicken wherein scientists had estimated 20000 to 23000 genes for chicken was released [23]. As a potential source of protein, many efforts have been made for both embryonic and adult chickens, ranging from the growth rate to meat yield, and the feeding strategies and efficiencies [24-26]. Studies have shown that breast muscle’s in vivo glycogen content correlates with meat quality [24]. On the other hand, it has been reviewed that continuous progress in optimizing meat and egg production has led to various disorders in metabolism and reproduction; then it has negative implications on humans as a result of consuming chicken’s meat and egg [25]. These obstacles can be overcome by diving more into chicken metabolism. In addition, there are also various metabolic disorders including those with environmental origins, such as oxygen or light regime, feeding strategy, as well as growth-related causes such as extraordinary growth. Some of these common disorders are fatal [27]. Thus, the development of a comprehensive metabolic model can be a platform to study the metabolism of chicken. Such model can also guide us to the treatment and even prevention of various diseases in the chicken.In this study, for the first time, a comprehensive genome-scale metabolic reconstruction for a chicken cell (named iES1300) was reconstructed. Flux balance analysis (FBA) [28], and single gene deletion as well as double gene deletion analyses were applied to compare robustness of iES1300 and three other important models for growth. Furthermore, transcriptomics data were integrated with iES1300 to construct four types of chicken cell lines, including fat, lean, normal, and tumor. The models were compared to determine essential metabolic differences for growth.
Material and methods
The procedure of genome-scale model reconstruction for gallus gallus
Fig 1 illustrates the overall procedure of iES1300 reconstruction and building specific models. Using the annotation of genome sequencing for Gallus gallus [23], a draft model was generated based on the reconstruction protocol [29]. For this purpose, we applied a pathway-by-pathway analysis of Gallus gallus metabolism. The draft consists of all metabolic reactions and their corresponding genes, enzymes, and metabolites collected from the KEGG [30], BiGG [31] and CHEBI [32] databases. To provide the draft of the model, the KEGG database was used to extract biological information of each gallus gallus metabolic pathway, including enzymes, reactions, and metabolites [30]. The reaction and metabolite identifiers were selected from the BiGG database to conform to community standards [31]. We also checked metabolites that did not exist in BiGG, their formula, and their charge by using the CHEBI database [32]. If there were not any reactions or metabolite names, we added new names. Regarding the naming of new added reactions and metabolites of metabolic pathways, KEGG reaction identifiers were used. For transport reactions, we used the MetaNetX database identifiers for metabolites and reactions [33]. Mass and charge balance as well as the reversibility of each reaction were also performed. Based on the literature, the intracellular pH of 7.2 was considered for charge balance [34]. This is also a typical pH value in the reconstruction of metabolic networks [29]. Moreover, gene-to-reaction association information was extracted from the related literature and gene orthology obtained from close organisms. Subcellular location information was taken from UNIPROT [35]. Information from CELLO [36] and EukmPLoc v2.0 [37] was also used for the prediction of cellular location when the localization information was not available in UNIPROT. These two databases use the amino acid sequence of the expressed protein in the FASTA format. CELLO can also use gene nucleotide sequences to predict the location of metabolic reactions. To find transport reactions, information from the REACTOME database was used [38]. Further, regarding lack of data for growth-associated maintenance (GAM) and some of the metabolites related to glycogen and lipid contents that appeared in the biomass formation reaction, these data were selected from the CHO model [19]. Furthermore, the amount of non-growth associated maintenance (NGAM) was taken from a mouse cell [39]. Also, for the biomass reaction generation, the existing information for chicken, including amino acid percentage and DNA components percentage was used. In addition, amino acid coefficients information was taken from the High-performance Integrated Virtual Environment (HIVE) database [40] and nucleotide information of the chicken genome data in NCBI [41]. More details about biomass reaction are available in the S2 File. The gap-filling process was also established so that the added reactions made the model capable of growing.
Fig 1
Schematic representation of (a) step-by-step genome-scale metabolic reconstruction and (b) using transcriptomics data extracted by online gene expression databases (c) to achieve context-specific models by the integration algorithms.
Schematic representation of (a) step-by-step genome-scale metabolic reconstruction and (b) using transcriptomics data extracted by online gene expression databases (c) to achieve context-specific models by the integration algorithms.
In silico simulations condition
To solve linear programming problems, Constraint-Based Reconstruction and Analysis (COBRA) toolbox in MATLAB 2017b software and the glpk solver package were utilized [42]. COBRA toolbox is a MATLAB package and has been developed to implement constraint based reconstruction and analysis methods; i.e. it allows researchers to infer and analyze reconstructed models [42]. In this way, COBRA toolbox has the capability of converting biological data into a mathematical model, then evaluate models by defining or changing objective functions, and improve the reconstructed model by deploying gap-filling process [42]. For intracellular reversible reactions, lower and upper bounds were set at -1000 and 1000 , respectively. Contrarily, for intracellular irreversible reactions, lower and upper bounds were set at 0 and 1000 , respectively. The upper bound of all the exchange reactions was set at 1000 . It is conventional that all reactions in metabolic models must have infinite lower and upper bounds to accept any flux. This infinity is shown by setting 1000 , as 1000 is considered to be a huge and infinite flux amount. An RPMI-like culture medium was also selected for the simulation of the medium, as it is proved to be one of the reliable culture media for growing chicken cells with respect to the studies on various types of chicken cells [43-45], and the lower bounds of exchange reactions were fixed based on [46]. Detailed components of the RPMI-like culture medium are represented in the S2 File. Besides, the biomass reaction was selected as the objective function in all of the simulations.
Comparison of the network
To date, a large number of studies have used different methods of network topology analysis to evaluate metabolic networks in terms of phylogenetic relationships [47]. Therefore, topology analysis of iES1300 was applied to see how phylogenetically close it is to its peers. We performed the single- and double-gene deletion analyses to compare iES1300 with the metabolic models of human (RECON1) [2], Saccharomyces cerevisiae (iMM904) [48], and Escherichia coli (iJO1366) [49] to evaluate all metabolic networks in terms of phylogenetic relationships [47]. It has to be mentioned that Single Gene Deletion is one of the COBRA toolbox analysis modules and calculates the effect of each gene on the cell growth one-by-one [42]. For Double Gene Deletion, the same procedure is also performed to remove the double genes. These analyses indicated that iES1300 was more flexible and robust compared to other prokaryotic and eukaryotic models. GR ratio (predicted growth rate after gene deletion per growth rate for wild type) was also applied to indicate the efficacy of single- or double-gene deletion. According to the method presented by [50], we defined a threshold on these growth rate ratios. In such a way that this ratio was lower than 10−5 for a particular gene, it must be a lethal gene, and if this ratio was just below 1 for other specific genes, it meant that those genes are categorized as sick genes. Therefore, we determined sick and lethal genes based on the single-gene deletion analysis, while the interactions of genes, synthetic lethal, and synthetic sick genes were specified based on the double-gene deletion analysis. Finally, to compare the four models, the results of the single-gene deletions and the number of interactions were normalized by dividing the number of genes in each model, whereas the results of the double-gene deletions were divided by the square of the number of genes in each model.
Integration of gene expression data
Considering HCC as an important disorder in the chickens liver [51], and the negative effects of adiposity on the economics of the poultry industries, especially in the case of meat quality [52], gene expression data from four species of chicken, including chicken liver control samples of hepatocellular carcinoma [53], normal cell lines [54], and adipose tissue samples of lean and fat [55] were taken from ArrayExpress, which is one of the largest online databases that acts as an archive of functional genomics data [56]. It was founded for microarray datasets at first, but the number of datasets submitted based on sequencing experiments has surprisingly been exceeded [56]. In our previous research [57], we indicated that TRFBA [58] and GIMME [59] are successful algorithms, especially for prediction of growth. So, both algorithms were applied to generate high-quality context-specific models. First, GIMME was used to remove reactions supported by genes with low expression levels. Then, TRFBA was employed to constrain the upper bound of the remaining reactions in the model according to the expression level of their supporting genes. In fact, TRFBA first converted all of the reversible reactions of a metabolic model into irreversible and “withoutOR”. Next, it added a set of constraints to limit the rate of reactions [58] as follows:Where vi is the reaction flux of i, Ej is the expression of the gene j, Kj is the set of indices of reactions supported by metabolic gene j, and C is a constant parameter that converts the expression levels to the upper bounds of the model reactions. This coefficient indicates the maximum rate supported by one unit of expression level of a gene; thus, the unit for C is mmol gDCW−1 h−1.The threshold value was set to the 25th percentile of the given expression data to inactivate reactions below a specific mRNA transcript level based on Machado and Herrgard study [60]. The second parameter for the objective function flux cutoff was used according to the original paper, i.e., the GIMME output context-specific metabolic network was forced to grow no less than 90% of the maximum growth [59]. The parameter of TRFBA (C) for each cell line was also changed in a stepwise approach according to the method presented in the next section.
Differentiation of cell lines using principal component analysis
After applying GIMME, the stepwise TRFBA was employed by stepwise change in C similar to the method presented by [57]. C was changed from zero to Cbrk with a step size of 0.1 of Cbrk, hence, nine flux distributions were constructed for each cell line. Cbrk is the point at which the growth rate does not change with an increase in the value of C [57]. In fact, TRFBA was used to maximize the growth rate for each cell. On the other hand, to avoid the well-known degeneracy of solutions, the Manhattan norm of the flux distribution was minimized while the optimal growth rate was given as constraint [61]. Correlated reactions with growth were determined for each cell line by calculating the Pearson correlation coefficient between each reaction flux and growth rate so that reactions with a coefficient more than 0.9 (P-value ≤ 0.05) were considered correlated. In the next step, the common growth-correlated reactions for the four cell lines were selected, and PCA was performed to differentiate the cell lines using the selected reactions.
Results and discussions
Characteristics of the reconstructed model
The reconstructed model contained 2427 biochemical reactions from 95 metabolic subsystems, 1300 genes, and 2569 metabolites. Of these reactions, 1910 reactions were gene-associated reactions and 295 of them were non-gene-associated. None-gene associated reactions, also known as orphan reactions, are those that have not yet been identified which genes or proteins are encoding them [62], but we added them to the model so that the model can grow. On the contrary, gene associated reactions are reactions for which a gene or several genes have been assigned [62]. Even the most comprehensive reconstructed models with highest confidence scores may have their own deficiencies [62]. This is mainly due to inadequate knowledge of the metabolism which leads to missing metabolites and reactions. For this reason, gap-filling is needed to refine the model inconsistencies [62]. To this end, for the growth of the chicken cell, we checked each component in the biomass production reaction to make sure they are not dead-end metabolites and see if they carry flux. During the gap-filling process, 67 reactions were added to the model to make it capable of growing. Fig 2A categorizes the reactions of iES1300 into nine main subsystems. As shown in this figure, among these subsystems, lipid and energy metabolism have the largest and the smallest distributions, respectively. Fig 2B, on the other side, determines that iES1300 consists of 10 subcellular locations, named cytosol, mitochondrion, extracellular space, endoplasmic reticulum, Golgi apparatus, lysosome, peroxisome, cytosolic membrane, endosome, and nucleus. This figure also shows that cytosol has the largest metabolite distribution. In Fig 2C, we can see similar as well as different reactions of iES1300 that compared with the two important mammalian metabolic GEMs. Fig 2C indicates that iES1300 has a relatively high similarity with the Recon2v4 and iCHOv1 networks. The new reactions of iES1300 may refer to the HMR reactions existing in the Recon3D reaction list used in iES1300, spontaneous reactions and also the reactions with different subcellular locations. Moreover, comparison of gene-associated reactions of iES1300 with three GEMs (Fig 2D) indicated that iES1300 had a lower ratio of non-gene-associated reactions to the total number of reactions of each model. To this end, we counted the number of reactions that had gene to reaction association and divided it by the number of all reactions in each model. Pseudo reactions are also referred to the exchange, demand, sink, biomass, and ATP maintenance reactions.
Fig 2
Characteristics of the reconstructed model.
(a) In iES1300, there are 9 main metabolism categories of which the lipid metabolism is responsible for the largest reaction distribution. (b) Cytosol is considered to have the largest metabolite distribution. (c) Investigating the number of reactions shared by three important mammalian models. The newly added reactions in iES1300 in comparison to the two other models can be discovered. (d) Examination of the gene-to-reaction association’s ratios (To the total number of reactions of each model) in the four important mammalian models exhibits that iES1300 has much lower orphan reactions compared to the other models.
Characteristics of the reconstructed model.
(a) In iES1300, there are 9 main metabolism categories of which the lipid metabolism is responsible for the largest reaction distribution. (b) Cytosol is considered to have the largest metabolite distribution. (c) Investigating the number of reactions shared by three important mammalian models. The newly added reactions in iES1300 in comparison to the two other models can be discovered. (d) Examination of the gene-to-reaction association’s ratios (To the total number of reactions of each model) in the four important mammalian models exhibits that iES1300 has much lower orphan reactions compared to the other models.
Comparison of iES1300 with the other eukaryotic and prokaryotic models
Three different types of organism cells were chosen to be compared with iES1300 using the single- and double-gene deletion analyses. Table 1 presents that the effect of single- and double-gene deletions on growth of multicellular organisms are much lower than those of unicellular organisms. The lower GR ratio of genes with interactions in two multicellular species also showed that compared with unicellular models, multicellular ones had more robustness and flexibility to genetic perturbations. In addition, the analyses confirmed that the trait of iES1300 was similar to the eukaryotic models.
Table 1
Results of single and double gene deletion analysis on four metabolic models using FBA approach.
Cell lines
Number of Genes
Ratios
Growth-Related Genes
Growth-Related Double-Genes
Genes with Interaction
iES1300
1300
0.05
0.0007
0.09
RECON1
1905
0.056
0.0002
0.07
iMM904
905
0.16
0.0014
0.016
iJO1366
1367
0.21
0.0013
0.15
Evaluation of metabolic similarities for cell lines
Growth vs. C/Cbrk for each model is presented in Fig 3. In this figure, we can see that the growth patterns of fat and tumor cell models are nearly analogous. In addition, metabolisms of lean model is more susceptible to the change of C compared to normal.
Fig 3
The different patterns of the growth sensitivity to the normalized parameter of TRFBA algorithm (C/Cbrk), are a source for differentiation of the four models.
Furthermore, by applying PCA for the common growth-related reactions, it was found that the normal and lean models were significantly different from tumor and fat models (Fig 4A). The PCA results also indicated that the normal chicken cell was the most different cell line from the lean, fat, and tumor cell lines. Fig 4B illustrates that by using the first principal component, 85% of the difference between normal cell metabolism and other cell lines can be explained. We further presented the difference of lean chicken cell with other cell lines by the second principal component with approximately 15% variance. It can be seen in Fig 4A that the fat model has metabolic similarities to tumor model. Therefore, we can state that the normal model had key metabolic differences from lean, fat, and tumor chick cell metabolisms. Focusing on these differences and targeting them can prevent such metabolic disorders in chickens. Results of PCA also verified that a considerable number of reactions that shifted along the PC2 were orthogonal to the reactions that appear in PC1, indicating that the lean and the normal models have presumably separate growth mechanisms.
Fig 4
PCA for extracting the reactions that play the role of biomarkers.
(a) PCA shows that the 36 flux distributions created by the combination of two integration algorithms, GIMME[59], and stepwise TRFBA[58] are successfully categorized into four different groups so that each group belongs to one cell line. (b) The variance explanation chart indicates that the 1st principal component is responsible for about 85% of the variance. The other 15% can be explained by the 2nd principal component. (c) The main differentiated reactions in PCA. 28 reactions are shown to have participated in the differentiation of the fat, lean, normal and tumor cells. Other reactions with lower absolute PC values were not investigated. The complete list of the reaction names is available in the S2 File.
PCA for extracting the reactions that play the role of biomarkers.
(a) PCA shows that the 36 flux distributions created by the combination of two integration algorithms, GIMME[59], and stepwise TRFBA[58] are successfully categorized into four different groups so that each group belongs to one cell line. (b) The variance explanation chart indicates that the 1st principal component is responsible for about 85% of the variance. The other 15% can be explained by the 2nd principal component. (c) The main differentiated reactions in PCA. 28 reactions are shown to have participated in the differentiation of the fat, lean, normal and tumor cells. Other reactions with lower absolute PC values were not investigated. The complete list of the reaction names is available in the S2 File.Fig 4C also shows the 28 main reactions in the differentiation of fat, lean, tumor, and normal chicken cell lines. Reactions with low values of absolute principal components were not considered because their differentiated flux distributions were insignificant.Besides, it is worth mentioning that the fat and tumor chicken models had strong resemblances, mostly because of their glucose, nucleotide, and lipid metabolism activities and many essential amino acid exchange reactions of these two models. These results are presented in the S2 File, where all the differentiated reactions in PCA are explained. Research works, especially in the field of obesity and Hepatocellular Carcinoma (HCC), indicated that in obesity, fat accumulation leads to liver malfunction, and consequently the liver cannot send out more triglycerides by very-low-density lipoprotein (VLDL) than that are synthesized. This intrahepatic triglyceride increasing would, in turn, result in fatty liver, and consequently liver failure and HCC [63, 64]. In the case of iES1300, lots of relationships and similarities were observed, especially in three pathways of lipid metabolism, including Fatty Acid Synthesis (FAS), sphingolipid, and glycerophospholipid metabolisms. Similarities in the flux patterns of FAS could lead both tumor and fat models to equally produce Palmitoyl-COA, which is a key metabolite in the progression of many other lipid pathways. Sphingolipid metabolism is one of the metabolic pathways, which is affected by FAS. This metabolic pathway is known for having some bioactive metabolites involved in the regulation of cell growth [65]. Therefore, it can be one of the primary sources of similarity in both models. Tracking sphingolipid and glycerophospholipid metabolisms has also revealed that some of their major metabolites play a key role in the biomass objective function reaction. Given that the nucleotides are widely used in various functions of all cells, and because of their relation with cell proliferation to DNA replication and RNA production [66], the more balance in the nucleotide metabolism activity could result in more equivalency of nucleotide production used for biomass generation. Moreover, it has been proved that obesity can systemically impact glucose metabolism by elevating glucose and insulin level, which favors cancer cell progression [67]. It can be presumed that the similarity in these three main metabolisms (glucose, nucleotide, and lipid metabolisms) controlling cell growth and proliferation affects the similarity between the amounts of many biomass reactants produced in tumor and fat models. This similarity could lead to the identical cell growth patterns in the tumor and fat models rather than the normal and lean models.PCA revealed that in the 1st Principal Component, which differentiated the normal chicken model from other models, especially tumor model, there were numerous distinguished reactions in three metabolisms, including nucleotide, carbohydrate, and lipid metabolism. Although number of these reactions were higher in the tumor cell metabolism than in the normal cells, the results demonstrated that glycolysis and pentose phosphate pathways were the most critical metabolic pathways in diversities of normal and tumor chicken models. It is also noteworthy that PC1 results of the 28 leading differentiated reactions indicated that the glycolysis pathway in tumor cell metabolism had higher activity toward the production of 3-phosphoglycerate, which is a key metabolite in the development of glycine, serine, and threonine metabolism. On this account, the tumor cells are expected to be more active than a normal cell in this metabolic pathway. This assertion could be justified by knowing that serine and glycine provide the main precursors for tumor cell metabolism [68]. It has been also observed that despite the fact that most reactions happen in the tumor cell, the normal cell could produce significant amounts of ribose-5-phosphate. Further investigations have shown that in the next step, this metabolite is converted to 5-phospho-ribose 1-diphosphate, which plays an influential role in the progression of nucleotide metabolism. It is important to note that nucleotides can be synthesizable from two main metabolisms of de novo synthesis and salvage pathways [66]. The proliferating cells such as cancer cells are more eager to synthesize their required nucleotides through de novo synthesis [69]. Similarly, in the present study, iES1300 demonstrated that the preference of normal chicken cell to use recycling of its nucleosides and nucleobases through salvage pathways is much higher than tumor cell.On the other side, for the 2nd Principal Component, which differentiated the lean cell line model from the others, especially fat model metabolism, various differentially flux distributions were observed. Results illustrated that in many metabolisms, because of several positive shifts along the PC2 axis, the metabolic activity of lean chicken can be more than that of fat chicken. However, a few of them were identified to be significant. Intriguingly, we perceived that the activity of enzyme phosphoglucomutase in the production of glucose-6-phosphate and the way it is used can be the dominant source of differences between lean and fat models. In the lean model, a considerable amount of glucose-6-phosphate heads towards inositol phosphate as well as ascorbate and aldarate metabolisms to produce significant amounts of uridine diphosphate glucose (UDPG). Since UDPG is a key precursor in starch and sucrose metabolism, it was expected that the lean model had much more activity on this pathway. Additional investigations indicated that the increase in activity of lean model was not due to glycogen production and storage, but it resulted from the production of glucose by 4-alpha-glucanotransferase. As a result, the starch and sucrose metabolism was considered a key metabolic pathway, and the principal source of cell metabolism for glucose generation and utilization. Glucose is consumed in the lean model at a significantly higher rate, even in adipose tissue. Previous studies on the relationship between glycogen and lipid oxidation in the liver and muscles have also shown that the glycogen storage reduction could increase lipid oxidation by stimulation of cellular energy state [70, 71]. Likewise, in obese adipocyte cell metabolism, the lower gene expression of fatty acid pathways because of defection in mitochondrial function resulting from a decrease in the mitochondrial acetyl-CoA concentration has already been established [14]. In this research work, iES1300 represented a significant diversity in the flux distributions of the lean and fat models, especially flux of three important reactions in cholesterol metabolism, fatty acid oxidation, and glyoxylate and dicarboxylate metabolism are significantly different. These reactions contributed to the production of mitochondrial acetyl-CoA and subsequently significant discrepancy in fatty acid oxidation metabolism was observed.
Conclusion
Chickens are the animals most associated with humans in rural life and animal husbandries to produce meat and egg. Therefore, understanding the chicken cell’s metabolism is beneficial to raise healthier chickens with a better feeding strategy and a higher meat quality. By reconstructing a consensus metabolic model for a chicken cell, one can deeply comprehend a chicken’s metabolism. The reconstructed model can then be used as a platform for other researchers to broaden their knowledge and studies of chicken cells’ metabolic interactions more efficiently. Accordingly, to reconstruct the first genome-scale metabolic model of the chicken cell, chicken’s biological and genomic data were manually collected in the form of a draft from different available bioinformatics databases. Afterwards, the model was curated by performing the gap-filling process. The final model consisted of 2427 reactions, 2569 metabolites, and 1300 genes. The chicken model was compared with three other important models to evaluate the interaction of metabolic gene networks, and this comparison demonstrated the relative similarity of the chicken’s gene network to human. After model reconstruction, the transcriptomics data of the four cell types of lean, fat, normal, and tumor were integrated using the two algorithms of GIMME and TRFBA. Finally, implementing PCA, we concluded that PCA has appropriately differentiated cell types from each other and recommended essential biomarkers. These biomarkers primarily participate in different metabolic pathways, such as carbohydrate metabolism, to distinguish normal cells from three other cell lines. Therefore, in addition to a general platform, we highlighted potential biomarkers that drugs can target to avoid chickens’ common metabolic diseases.
The Excel and SBML version of the reconstructed model.
In this supplementary file, a zip file containing the Excel and SBML version of the reconstructed chicken cell model is attached.(RAR)Click here for additional data file.
Detailed information of the model.
In this supplementary file, detailed information in the form of Excel sheets that has been mentioned in the paper including protein and DNA components coefficients, simulated growth medium, all and the main differentiated reactions from PCA results are available.(XLSX)Click here for additional data file.28 Dec 2021
PONE-D-21-17962
Reconstruction of a generic genome-scale metabolic network for chicken: investigating network connectivity and finding potential biomarkers
PLOS ONE
Dear Dr. Shojaosadati,Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.Please submit your revised manuscript by Feb 11 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.We look forward to receiving your revised manuscript.Kind regards,Mingzhi LiaoAcademic EditorPLOS ONEJournal Requirements:When submitting your revision, we need you to address these additional requirements.1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found athttps://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf andhttps://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.Upon resubmission, please provide the following:The name of the colleague or the details of the professional service that edited your manuscriptA copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)3. Please upload a new copy of Figures 1, 2, 3 and 4 as the detail is not clear. Please follow the link for more information: " ext-link-type="uri" xlink:type="simple">https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/"
" ext-link-type="uri" xlink:type="simple">https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/"4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.[Note: HTML markup is below. Please do not edit.]Reviewers' comments:Reviewer's Responses to Questions
Comments to the Author1. Is the manuscript technically sound, and do the data support the conclusions?The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: YesReviewer #2: Yes********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: YesReviewer #2: Yes********** 3. Have the authors made all data underlying the findings in their manuscript fully available?The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: YesReviewer #2: Yes********** 4. Is the manuscript presented in an intelligible fashion and written in standard English?PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: YesReviewer #2: Yes********** 5. Review Comments to the AuthorPlease use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Your interest of research is good. Revise your manuscript accordingly and revise the grammatical errors in the paper explain all the possible terms mentioned in the paper as they are described not properly through the manuscriptReviewer #2: In this manuscript, the authors reconstructed a generic genome-scale metabolic network for chicken named iES1300, which was consists of 2427 reactions, 2526 metabolites, and 1300 genes. In addition, they compared the iES1300 with three other important models to evaluate the interaction of metabolic gene networks. Meanwhile, they found several important biomarkers based on PCA. Overall, this work is meaningful and well-organized.However, the whole manuscript has bioinformatics results only. In order to illustrate the reliability of those biomarkers, in vitro or in vivo biochemical verification is suggested.1.In“2.1 The procedure of genome-scale model reconstruction for gallus gallus” part, it will be helpful to explain the rules and the basis for adding new name for those reactions or metabolite which have no name.2.In “2.2 In silico simulations condition”, is there any reference for the setting of the reaction upper and lower bounds?3.In “3.1 Characteristics of the reconstructed model” part, it is better to add the calculation of network correlation to illustrate the similarity between the networks.4.In the discussion part, it's suggested to include some critical thinking and exemplify the application of this research.5.Please pay attention to the inconsistency in font and case, such as “by” in line 234, and “Metabolisms” in line 267.********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.If you choose “no”, your identity will remain anonymous but your review may still be made public.Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: NoReviewer #2: No[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
Submitted filename: comments.docxClick here for additional data file.19 Feb 2022We would like to greatly appreciate your attention to our manuscript. We acknowledge that our manuscript is reinforced after the revisions applied to the manuscript based on the constructive comments received from the professional editor and reviewer. As requested, the questions and comments are answered and addressed below meticulously. We also used both highlighting and track changes. The edited manuscript is attached, as well. We hope the major and minor revisions serve to draw your attention to find the manuscript worthy of publication.Thank you again for perusing this context. We would welcome any further specific questions you might have.Submitted filename: Response to Reviewers.docxClick here for additional data file.8 Mar 2022Reconstruction of a generic genome-scale metabolic network for chicken: investigating network connectivity and finding potential biomarkersPONE-D-21-17962R1Dear Dr. Shojaosadati,We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.Kind regards,Mingzhi LiaoAcademic EditorPLOS ONEAdditional Editor Comments (optional):All issues have been solved.Reviewers' comments:12 Mar 2022PONE-D-21-17962R1Reconstruction of a generic genome-scale metabolic network for chicken: investigating network connectivity and finding potential biomarkersDear Dr. Shojaosadati:I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.If we can help with anything else, please email us at plosone@plos.org.Thank you for submitting your work to PLOS ONE and supporting open access.Kind regards,PLOS ONE Editorial Office Staffon behalf ofDr. Mingzhi LiaoAcademic EditorPLOS ONE
Authors: Zachary A King; Justin Lu; Andreas Dräger; Philip Miller; Stephen Federowicz; Joshua A Lerman; Ali Ebrahim; Bernhard O Palsson; Nathan E Lewis Journal: Nucleic Acids Res Date: 2015-10-17 Impact factor: 16.971
Authors: Adil Mardinoglu; Rasmus Agren; Caroline Kampf; Anna Asplund; Intawat Nookaew; Peter Jacobson; Andrew J Walley; Philippe Froguel; Lena M Carlsson; Mathias Uhlen; Jens Nielsen Journal: Mol Syst Biol Date: 2013 Impact factor: 11.429